Tags

Type your tag names separated by a space and hit enter

Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer.
Can Urol Assoc J 2019; 13(12):404-405CU

Authors+Show Affiliations

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31799923

Citation

Sridhar, Srikala S.. "Balancing Efficacy and Financial Toxicity in the Management of Metastatic Castration-sensitive Prostate Cancer." Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada, vol. 13, no. 12, 2019, pp. 404-405.
Sridhar SS. Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer. Can Urol Assoc J. 2019;13(12):404-405.
Sridhar, S. S. (2019). Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer. Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada, 13(12), pp. 404-405. doi:10.5489/cuaj.6346.
Sridhar SS. Balancing Efficacy and Financial Toxicity in the Management of Metastatic Castration-sensitive Prostate Cancer. Can Urol Assoc J. 2019;13(12):404-405. PubMed PMID: 31799923.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer. A1 - Sridhar,Srikala S, PY - 2019/12/5/entrez PY - 2019/12/5/pubmed PY - 2019/12/5/medline SP - 404 EP - 405 JF - Canadian Urological Association journal = Journal de l'Association des urologues du Canada JO - Can Urol Assoc J VL - 13 IS - 12 SN - 1911-6470 UR - https://www.unboundmedicine.com/medline/citation/31799923/Balancing_efficacy_and_financial_toxicity_in_the_management_of_metastatic_castration-sensitive_prostate_cancer L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31799923/ DB - PRIME DP - Unbound Medicine ER -